- Home
- IMRN vs HSCS Comparison
IMRN vs HSCS Comparison
Compare IMRN & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- HSCS
- Stock Information
- Founded
- IMRN 1994
- HSCS 2007
- Country
- IMRN Australia
- HSCS United States
- Employees
- IMRN N/A
- HSCS N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- HSCS Medical Specialities
- Sector
- IMRN Health Care
- HSCS Health Care
- Exchange
- IMRN Nasdaq
- HSCS Nasdaq
- Market Cap
- IMRN 9.2M
- HSCS 8.7M
- IPO Year
- IMRN N/A
- HSCS 2022
- Fundamental
- Price
- IMRN $1.80
- HSCS $3.49
- Analyst Decision
- IMRN Strong Buy
- HSCS Strong Buy
- Analyst Count
- IMRN 1
- HSCS 2
- Target Price
- IMRN $5.00
- HSCS $13.00
- AVG Volume (30 Days)
- IMRN 46.0K
- HSCS 87.4K
- Earning Date
- IMRN 08-29-2025
- HSCS 09-11-2025
- Dividend Yield
- IMRN N/A
- HSCS N/A
- EPS Growth
- IMRN N/A
- HSCS N/A
- EPS
- IMRN N/A
- HSCS N/A
- Revenue
- IMRN $4,777,422.00
- HSCS $6,250.00
- Revenue This Year
- IMRN N/A
- HSCS $13,968.97
- Revenue Next Year
- IMRN N/A
- HSCS $166.67
- P/E Ratio
- IMRN N/A
- HSCS N/A
- Revenue Growth
- IMRN 48.63
- HSCS N/A
- 52 Week Low
- IMRN $1.50
- HSCS $2.52
- 52 Week High
- IMRN $2.87
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- IMRN 48.13
- HSCS 51.67
- Support Level
- IMRN $1.80
- HSCS $3.00
- Resistance Level
- IMRN $1.94
- HSCS $3.70
- Average True Range (ATR)
- IMRN 0.08
- HSCS 0.20
- MACD
- IMRN -0.01
- HSCS 0.02
- Stochastic Oscillator
- IMRN 22.22
- HSCS 70.00
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.